ARS PHARMACEUTICALS, INC. (SPRY)
ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2026 Financial Results
ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2026 Financial Results
Uber Eats and Ulta Beauty Team Up to Deliver Beauty Essentials Nationwide, Expanding On-Demand Access to Both Prestige and Mass Favorites
ArriVent Announces IND Clearance for Novel Tetravalent MUC16/NaPi2b Targeting ADC ARR-002 with Initial Focus in Ovarian and Endometrial Cancers
ClearBridge Energy Midstream Opportunity Fund Inc. Announces Unaudited Balance Sheet Information as of April 30, 2026
LegalZoom Reinvents Virtual Mail with AI to Help Small Businesses Save Time and Protect Privacy
Charles River Associates (CRA) Declares Quarterly Cash Dividend of $0.57 Per Common Share
WisdomTree Launches Efficient Rare Earth Plus Strategic Metals Fund (WDIG)
Fifth Third Closes Fannie Mae DUS® Acquisition; Strengthens Multifamily Lending Capabilities
ALX Oncology’s Evorpacept in Combination with Zanidatamab Generates Promising, Durable Response in Patients with Advanced HER2-Positive Breast Cancer and High CD47 Expression
Shakeology by BODi Enters Retail Stores Nationwide, Marking a Major Expansion in the Company’s Nutrition-Led Strategy
Kustom Entertainment Engages Rosen Group to Expand Media Visibility
MediWound to Report First Quarter 2026 Financial Results
Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026 and Provides Update on Recent Business Progress
Everest Appoints Lisa Davis to Lead North America Wholesale & Specialty Business
Core Molding Technologies Reports Fiscal 2026 First Quarter Results